Budesonide And Formoterol Fumarate Dihydrate Aerosol
Product Images NDC 50090-6382

Product Visual Gallery

This gallery contains 17 technical images submitted to the FDA as part of the official labeling for Budesonide And Formoterol Fumarate Dihydrate (NDC 50090-6382). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Counter Image 15 (308708 Rapihaler Counter 15 (black;130;485))

FDA Label Image

Counter Image 80 (308710 Rapihaler Counter 80 (black;130;485))

FDA Label Image

Figure 1 (Figure1bodytext)

This appears to be a table showing results of a treatment involving Budesonide and Formoterol Fumarate Dihydrate inhalers of varying doses. The table compares the efficacy of the inhalers against a placebo. Two inhalations are required daily for all variants of the inhaler treatment.*

FDA Label Image

Figure 2 (Figure2bodytext)

FDA Label Image

Figure 3 (Figure3bodytext)

FDA Label Image

Figure 4 (Figure4bodytext)

This text presents a graph showing the percent change from baseline in FEV over 12 hours after the administration of Budesonide and Formoterol Fumarate Dihydrate 160/4.5 meg inhalations. The graph shows an initial percent increase followed by a slight percent decrease over time. There is also information about the dosage of the medication used, as well as a mention of a placebo.*

FDA Label Image

Figure 5 (Figure5bodytext)

FDA Label Image

Figure 6 (Figure6bodytext)

This appears to be a chart or table showing some kind of data related to medication dosages and their effects on pre-dose FEV (forced expiratory volume) in patients. The medications listed include Budesonide, Formoterol Fumarate Dihydrate, and combinations of the two, as well as a placebo. The dosage amounts are given in meg (presumably micrograms, abbreviated incorrectly) or mcg per inhalation, with varying numbers of inhalations per dose, and the data includes numerical values for percent change from a baseline. It's not clear what condition or study this data is related to.*

FDA Label Image

Figure 7 (Figure7bodytext)

The text is a table presenting the percent change from baseline in 1-hour post-dose FEV for different treatments including Budesonide, Formoterol Fumarate Dihydrate, and Placebo over a period of 6 months. The table shows the number of participants (N) in each treatment group and the mean percent change from the baseline at different time points. The treatments tested are Budesonide and Formoterol Fumarate Dihydrate MDI 160/4.5 meg, two inhalations twice daily; Budesonide 160 mcg, two inhalations twice daily; Formoterol 4.5 meg, two inhalations twice daily; Budesonide 160 mcg + Formoterol 4.5 meg, two inhalations twice daily; and Placebo.*

FDA Label Image

Budesonide Structural Formula (Image 01)

FDA Label Image

Structural Fumarate (Image 02)

FDA Label Image

Figure 1 (Image 03)

The text seems to be an illustration of some physical device which comprises a counter with a canister inside, a mouthpiece, a strap, and a mouthpiece cover. Not available.*

FDA Label Image

Figure 2 Gray Arrows (Image 04)

FDA Label Image

Figure 3 (Image 05)

FDA Label Image

Figure 4 (Image 06)

FDA Label Image

Figure 5 (Image 07)

FDA Label Image

Label Image (Lbl500906382)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.